Caricamento...
Aprepitant for the management of nausea with inpatient IV dihydroergotamine
OBJECTIVE: To assess the efficacy and tolerability of oral aprepitant, a substance P/neurokinin A receptor antagonist, in controlling nausea associated with IV dihydroergotamine (DHE) administered for medically refractory migrainous headache in patients not responding to standard antiemetics or with...
Salvato in:
| Pubblicato in: | Neurology |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Lippincott Williams & Wilkins
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5067541/ https://ncbi.nlm.nih.gov/pubmed/27629088 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000003206 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|